{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T21:34:56Z","timestamp":1776980096495,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100000380","name":"Guys and St Thomas' Charity","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100000380","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009794","name":"Breast Cancer Now","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s13058-016-0789-y","type":"journal-article","created":{"date-parts":[[2017,1,17]],"date-time":"2017-01-17T03:59:22Z","timestamp":1484625562000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression"],"prefix":"10.1186","volume":"19","author":[{"given":"Vandna","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salpie","family":"Nowinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Levi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irek","family":"Shinomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narda","family":"Kebaier Ep Chaabouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Gillett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"Grigoriadis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trevor A.","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Roylance","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah E.","family":"Pinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elinor J.","family":"Sawyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,17]]},"reference":[{"issue":"12","key":"789_CR1","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.20273","volume":"100","author":"ES Hwang","year":"2004","unstructured":"Hwang ES, Nyante SJ, Yi Chen Y, Moore D, DeVries S, Korkola JE, Esserman LJ, Waldman FM. Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma. Cancer. 2004;100(12):2562\u201372.","journal-title":"Cancer"},{"issue":"9","key":"789_CR2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/bjc.1997.523","volume":"76","author":"CB Vos","year":"1997","unstructured":"Vos CB, Cleton-Jansen AM, Berx G, de Leeuw WJ, ter Haar NT, van Roy F, Cornelisse CJ, Peterse JL, van de Vijver MJ. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer. 1997;76(9):1131\u20133.","journal-title":"Br J Cancer"},{"issue":"9205","key":"789_CR3","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(99)03703-4","volume":"355","author":"F W\u00e4rnderg","year":"2000","unstructured":"W\u00e4rnderg F, Yuen J, Holmberg L. Risk of subsequent invasive breast cancer after breast carcinoma in situ. Lancet. 2000;355(9205):724\u20135.","journal-title":"Lancet"},{"issue":"9","key":"789_CR4","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1002\/cncr.20979","volume":"103","author":"LC Collins","year":"2005","unstructured":"Collins LC, Tamimi RM, Baer HJ, et al. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses\u2019 Health Study. Cancer. 2005;103(9):1778\u201384.","journal-title":"Cancer"},{"issue":"7","key":"789_CR5","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.prp.2016.05.002","volume":"212","author":"M Christgen","year":"2016","unstructured":"Christgen M, Steinemann D, K\u00fchnle E, L\u00e4nger F, Gluz O, Harbeck N, Kreipe H. Lobular breast cancer: clinical, molecular and morphological characteristics. Pathol Res Pract. 2016;212(7):583\u201397.","journal-title":"Pathol Res Pract"},{"issue":"33","key":"789_CR6","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","volume":"33","author":"TA King","year":"2015","unstructured":"King TA, Pilewskie M, Muhsen S, Patil S, Mautner SK, Park A, Oskar S, Guerini-Rocco E, Boafo C, Gooch JC, De Brot M, Reis-Filho JS, Morrogh M, Andrade VP, Sakr RA, Morrow M. Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk. J Clin Oncol. 2015;33(33):3945\u201352.","journal-title":"J Clin Oncol"},{"issue":"24","key":"789_CR7","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","volume":"23","author":"PJ Chuba","year":"2005","unstructured":"Chuba PJ, Hamre MR, Yap J, Severson RK, Lucas D, et al. Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data. J Clin Oncol. 2005;23(24):5534\u201341.","journal-title":"J Clin Oncol"},{"issue":"2","key":"789_CR8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/cncr.11883","volume":"100","author":"ER Fisher","year":"2004","unstructured":"Fisher ER, Land SR, Fisher B, Mamounas E, Gilarski L, et al. Pathologic findings from the NSABBP: twelve-year observations concerning lobular carcinoma in situ. Cancer. 2004;100(2):238\u201344.","journal-title":"Cancer"},{"issue":"11","key":"789_CR9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/gcc.20368","volume":"45","author":"TL Mastracci","year":"2006","unstructured":"Mastracci TL, Shadeo A, Colby SM, Tuck AB, O\u2019Malley FP, Bull SB, Lam WL, Andrulis IL. Genomic alterations in lobular neoplasia: a microarray comparative genomic hybridization signature for early neoplastic proliferation in the breast. Genes Chromosomes Cancer. 2006;45(11):1007\u201317.","journal-title":"Genes Chromosomes Cancer"},{"key":"789_CR10","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1053\/hupa.2001.22759","volume":"32","author":"JE Etzell","year":"2001","unstructured":"Etzell JE, Devries S, Chew K, Florendo C, Molinaro A, Ljung BM, Waldman FM. Loss of chromosome 16q in lobular carcinoma in situ. Hum Pathol. 2001;32:292\u20136.","journal-title":"Hum Pathol"},{"issue":"6","key":"789_CR11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/modpathol.3800362","volume":"18","author":"TL Mastracci","year":"2005","unstructured":"Mastracci TL, Tjan S, Bane AL, O\u2019Malley FP, Andrulis IL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol. 2005;18(6):741\u201351.","journal-title":"Mod Pathol"},{"issue":"4","key":"789_CR12","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","volume":"14","author":"CI Li","year":"2005","unstructured":"Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14(4):1008\u201311.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"789_CR13","doi-asserted-by":"crossref","first-page":"S1526","DOI":"10.1016\/j.clbc.2016.06.003","volume":"16","author":"B Susnik","year":"2016","unstructured":"Susnik B, Day D, Abeln E, Bowman T, Krueger J, Swenson KK, Tsai ML, Bretzke ML, Lillemoe TJ. Surgical outcomes of lobular neoplasia diagnosed in core biopsy: prospective study of 316 cases. Clin Breast Cancer. 2016;16:S1526\u20138209.","journal-title":"Clin Breast Cancer"},{"issue":"22","key":"789_CR14","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1093\/jnci\/dji372","volume":"97","author":"B Fisher","year":"2005","unstructured":"Fisher B, Costantino JP, Wickerham DL, Cecchini RS, Cronin WM, Robidoux A, Bevers TB, Kavanah MT, Atkins JN, Margolese RG, Runowicz CD, James JM, Ford LG, Wolmark N. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI. 2005;97(22):1652\u201362.","journal-title":"JNCI"},{"key":"789_CR15","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1056\/NEJMoa1103507","volume":"364","author":"PE Goss","year":"2011","unstructured":"Goss PE, Ingle JN, Ales-Martinez JE, et al. Exemestane for breast-cancer prevention in postmenopausal women. N Engl J Med. 2011;364:2381\u201391.","journal-title":"N Engl J Med"},{"key":"789_CR16","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s13058-015-0580-5","volume":"17","author":"GJ Logan","year":"2015","unstructured":"Logan GJ, Dabbs DJ, Lucas PC, Jankowitz RC, Brown DD, Clark BZ, Oesterreich S, McAuliffe PF. Molecular drivers of lobular carcinoma in situ. Breast Cancer Res. 2015;17:76.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"789_CR17","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.breast.2012.03.005","volume":"21","author":"A Vincent-Salomon","year":"2012","unstructured":"Vincent-Salomon A, Hajage D, Rouquette A, C\u00e9denot A, Gruel N, Alran S, Sastre-Garau X, Sigal-Zafrani B, Fourquet A, Kirova Y. High Ki67 expression is a risk marker of invasive relapse for classical lobular carcinoma in situ patients. Breast. 2012;21(3):380\u20133.","journal-title":"Breast"},{"issue":"1","key":"789_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/path.2978","volume":"226","author":"O Giricz","year":"2012","unstructured":"Giricz O, Reynolds PA, Ramnauth A, Liu C, Wang T, Stead L, Childs G, Rohan T, Shapiro N, Fineberg S, Kenny PA, Loudig O. Hsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity. J Pathol. 2012;226(1):108\u201319.","journal-title":"J Pathol"},{"issue":"3","key":"789_CR19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s10549-004-4493-8","volume":"90","author":"SK Mohsin","year":"2005","unstructured":"Mohsin SK, O\u2019Connell P, Allred DC, Libby AL. Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res Treat. 2005;90(3):249\u201356.","journal-title":"Breast Cancer Res Treat"},{"key":"789_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1186\/1471-2164-13-591","volume":"13","author":"G Nilsen","year":"2012","unstructured":"Nilsen G, Liest\u00f8l K, Van Loo P, Moen Vollan HK, Eide MB, Rueda OM, Chin SF, Russell R, Baumbusch LO, Caldas C, B\u00f8rresen-Dale AL, Lingjaerde OC. Copynumber: efficient algorithms for single- and multi-track copy number segmentation. BMC Genomics. 2012;13:591.","journal-title":"BMC Genomics"},{"issue":"7","key":"789_CR21","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/modpathol.3800621","volume":"19","author":"JS Reis-Filho","year":"2006","unstructured":"Reis-Filho JS, Savage K, Lambros MB, James M, Steele D, Jones RL, Dowsett M. Cyclin D1 protein overexpression and CCND1 amplification in breast carcinomas: an immunohistochemical and chromogenic in situ hybridisation analysis. Mod Pathol. 2006;19(7):999\u20131009.","journal-title":"Mod Pathol"},{"issue":"16","key":"789_CR22","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G, Abecasis G, Durbin R. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"3","key":"789_CR23","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1101\/gr.129684.111","volume":"22","author":"DC Koboldt","year":"2012","unstructured":"Koboldt DC, Zhang Q, Larson DE, Shen D, McLellan MD, Lin L, Miller CA, Mardis ER, Ding L, Wilson RK. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 2012;22(3):568\u201376.","journal-title":"Genome Res"},{"issue":"16","key":"789_CR24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):164.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"789_CR25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/ijc.23217","volume":"122","author":"W Qiu","year":"2008","unstructured":"Qiu W, Tong GX, Manolidis S, Close LG, Assaad AM, Su GH. Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer. Int J Cancer. 2008;122(5):1189\u201394.","journal-title":"Int J Cancer"},{"issue":"8","key":"789_CR26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/1042819031000079168","volume":"44","author":"P Hui","year":"2003","unstructured":"Hui P, Howe JG, Crouch J, Nimmakayalu M, Qumsiyeh MB, Tallini G, Flynn SD, Smith BR. Real-time quantitative RT-PCR of cyclin D1 mRNA in mantle cell lymphoma: comparison with FISH and immunohistochemistry. Leuk Lymphoma. 2003;44(8):1385\u201394.","journal-title":"Leuk Lymphoma"},{"issue":"49","key":"789_CR27","doi-asserted-by":"crossref","first-page":"17606","DOI":"10.1073\/pnas.1408650111","volume":"111","author":"M Mohseni","year":"2014","unstructured":"Mohseni M, Cidado J, Croessmann S, Cravero K, Cimino-Mathews A, Wong HY, Scharpf R, Zabransky DJ, Abukhdeir AM, Garay JP, Wang GM, Beaver JA, Cochran RL, Blair BG, Rosen DM, Erlanger B, Argani P, Hurley PJ, Lauring J, Park BH. MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast cancers. PNAS. 2014;111(49):17606\u201311.","journal-title":"PNAS"},{"issue":"4","key":"789_CR28","doi-asserted-by":"crossref","first-page":"248","DOI":"10.18632\/oncoscience.34","volume":"1","author":"J Zhao","year":"2014","unstructured":"Zhao J. KLF8: so different in ovarian and breast cancer. Oncoscience. 2014;1(4):248\u20139.","journal-title":"Oncoscience"},{"issue":"10","key":"789_CR29","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1177\/1947601910395583","volume":"1","author":"E Bilal","year":"2010","unstructured":"Bilal E, Alexe G, Yao M, Cong L, Kulkarni A, Ginjala V, Toppmeyer D, Ganesan S, Bhanot G. Identification of the YES1 kinase as a therapeutic target in basal-like breast cancers. Genes Cancer. 2010;1(10):1063\u201373.","journal-title":"Genes Cancer"},{"issue":"3","key":"789_CR30","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s10549-011-1835-1","volume":"133","author":"CE Johnson","year":"2012","unstructured":"Johnson CE, Gorringe KL, Thompson ER, Opeskin K, Boyle SE, Wang Y, Hill P, Mann GB, Campbell IG. Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma. Breast Cancer Res Treat. 2012;133(3):889\u201398.","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"789_CR31","doi-asserted-by":"crossref","first-page":"e81843","DOI":"10.1371\/journal.pone.0081843","volume":"9","author":"S Cornen","year":"2014","unstructured":"Cornen S, Guille A, Ad\u00e9la\u00efde J, Addou-Klouche L, Finetti P, Saade MR, Manai M, Carbuccia N, Bekhouche I, Letessier A, Raynaud S, Charafe-Jauffret E, Jacquemier J, Spicuglia S, de The H, Viens P, Bertucci F, Birnbaum D, Chaffanet M. Candidate luminal B breast cancer genes identified by genome, gene expression and DNA methylation profiling. PLoS One. 2014;9(1):e81843.","journal-title":"PLoS One"},{"issue":"7","key":"789_CR32","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1080\/15384047.2015.1046025","volume":"16","author":"P Lebok","year":"2015","unstructured":"Lebok P, Mittenzwei A, Kluth M, \u00d6zden C, Taskin B, Hussein K, M\u00f6ller K, Hartmann A, Lebeau A, Witzel I, Mahner S, W\u00f6lber L, J\u00e4nicke F, Geist S, Paluchowski P, Wilke C, Heilenk\u00f6tter U, Simon R, Sauter G, Terracciano L, Krech R, von der Assen A, M\u00fcller V, Burandt E. 8p Deletion is strongly linked to poor prognosis in breast cancer. Cancer Biol Ther. 2015;16(7):1080\u20137.","journal-title":"Cancer Biol Ther"},{"issue":"3","key":"789_CR33","doi-asserted-by":"crossref","first-page":"e54643","DOI":"10.1371\/journal.pone.0054643","volume":"8","author":"T Venkatesh","year":"2013","unstructured":"Venkatesh T, Nagashri MN, Swamy SS, Mohiyuddin SM, Gopinath KS, Kumar A. Primary microcephaly gene MCPH1 shows signatures of tumor suppressors and is regulated by miR-27a in oral squamous cell carcinoma. PLoS One. 2013;8(3):e54643.","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"789_CR34","doi-asserted-by":"crossref","first-page":"S424","DOI":"10.1245\/s10434-012-2715-6","volume":"20","author":"N Bhattacharya","year":"2013","unstructured":"Bhattacharya N, Mukherjee N, Singh RK, Sinha S, Alam N, Roy A, Roychoudhury S, Panda CK. Frequent alterations of MCPH1 and ATM are associated with primary breast carcinoma: clinical and prognostic implications. Ann Surg Oncol. 2013;20 Suppl 3:S424\u201332.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"789_CR35","doi-asserted-by":"crossref","first-page":"e1005816","DOI":"10.1371\/journal.pgen.1005816","volume":"12","author":"T Mantere","year":"2016","unstructured":"Mantere T, Winqvist R, Kauppila S, Grip M, Jukkola-Vuorinen A, Tervasm\u00e4ki A, Rapakko K, Pylk\u00e4s K. Targeted next-generation sequencing identifies a recurrent mutation in MCPH1 associating with hereditary breast cancer susceptibility. PLoS Genet. 2016;12(1):e1005816.","journal-title":"PLoS Genet"},{"issue":"11","key":"789_CR36","first-page":"2836","volume":"60","author":"A Castells","year":"2000","unstructured":"Castells A, Gusella JF, Ramesh V, Rustgi AK. A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers. Cancer Res. 2000;60(11):2836\u20139.","journal-title":"Cancer Res"},{"key":"789_CR37","first-page":"4721","volume":"58","author":"YJ Lu","year":"1998","unstructured":"Lu YJ, Osin P, Lakhani SR, Di Palma S, Gusterson BA, Shipley JM. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res. 1998;58:4721\u20137.","journal-title":"Cancer Res"},{"issue":"19","key":"789_CR38","first-page":"4360","volume":"57","author":"F Courjal","year":"1997","unstructured":"Courjal F, Cuny M, Simony-Lafontaine J, Louason G, Speiser P, Zeillinger R, Rodriguez C, Theillet C. Mapping of DNA amplifications at 15 chromosomal localizations in 1875 breast tumors: definition of phenotypic groups. Cancer Res. 1997;57(19):4360\u20137.","journal-title":"Cancer Res"},{"issue":"4","key":"789_CR39","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/bcr3239","volume":"14","author":"M Jang","year":"2012","unstructured":"Jang M, Kim E, Choi Y, Lee H, Kim Y, Kim J, Kang E, Kim SW, Kim I, Park S. FGFR1 is amplified during the progression of in situ to invasive breast carcinoma. Breast Cancer Res. 2012;14(4):R115.","journal-title":"Breast Cancer Res"},{"issue":"3","key":"789_CR40","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10549-009-0675-8","volume":"123","author":"L Burkhardt","year":"2010","unstructured":"Burkhardt L, Grob TJ, Hermann I, Burandt E, Choschzick M, J\u00e4nicke F, M\u00fcller V, Bokemeyer C, Simon R, Sauter G, Wilczak W, Lebeau A. Gene amplification in ductal carcinoma in situ of the breast. Breast Cancer Res Treat. 2010;123(3):757\u201365.","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"789_CR41","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.humpath.2013.04.004","volume":"44","author":"SJ Shin","year":"2013","unstructured":"Shin SJ, Lal A, De Vries S, Suzuki J, Roy R, Hwang ES, Schnitt SJ, Waldman FM, Chen YY. Florid lobular carcinoma in situ: molecular profiling and comparison to classic lobular carcinoma in situ and pleomorphic lobular carcinoma in situ. Hum Pathol. 2013;44(10):1998\u20132009.","journal-title":"Hum Pathol"},{"issue":"1","key":"789_CR42","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s12282-014-0538-y","volume":"23","author":"E Burandt","year":"2016","unstructured":"Burandt E, Gr\u00fcnert M, Lebeau A, Choschzick M, Quaas A, J\u00e4nicke F, M\u00fcller V, Scholz U, Bokemeyer C, Petersen C, Geist S, Paluchowski P, Wilke C, Heilenk\u00f6tter U, Simon R, Sauter G, Wilczak W. Cyclin D1 gene amplification is highly homogeneous in breast cancer. Breast Cancer. 2016;23(1):111\u20139.","journal-title":"Breast Cancer"},{"issue":"11","key":"789_CR43","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.humpath.2012.02.015","volume":"43","author":"NP Tobin","year":"2012","unstructured":"Tobin NP, Lundgren KL, Conway C, Anagnostaki L, Costello S, Landberg G. Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information. Hum Pathol. 2012;43(11):2053\u201361.","journal-title":"Hum Pathol"},{"issue":"13","key":"789_CR44","first-page":"2876","volume":"58","author":"T Oyama","year":"1998","unstructured":"Oyama T, Kashiwabara K, Yoshimoto K, Arnold A, Koerner F. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Cancer Res. 1998;58(13):2876\u201380.","journal-title":"Cancer Res"},{"issue":"8","key":"789_CR45","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/s13059-014-0431-1","volume":"15","author":"HR Ali","year":"2014","unstructured":"Ali HR, Rueda OM, Chin SF, Curtis C, Dunning MJ, Aparicio SA, Caldas C. Genome-driven integrated classification of breast cancer validated in over 7,500 samples. Genome Biol. 2014;15(8):431.","journal-title":"Genome Biol"},{"issue":"13","key":"789_CR46","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1016\/j.ejca.2010.05.013","volume":"46","author":"N Gruel","year":"2010","unstructured":"Gruel N, Lucchesi C, Raynal V, Rodrigues MJ, Pierron G, Goudefroye R, Cottu P, Reyal F, Sastre-Garau X, Fourquet A, Delattre O, Vincent-Salomon A. Lobular invasive carcinoma of the breast is a molecular entity distinct from luminal invasive ductal carcinoma. Eur J Cancer. 2010;46(13):2399\u2013407.","journal-title":"Eur J Cancer"},{"issue":"2","key":"789_CR47","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.cell.2015.09.033","volume":"163","author":"G Ciriello","year":"2015","unstructured":"Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA. TCGA Research Network, Perou CM. Comprehensive molecular portraits of invasive lobular breast cancer. Cell. 2015;163(2):506\u201319.","journal-title":"Cell"},{"key":"789_CR48","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.molonc.2015.11.001","volume":"10","author":"RA Sakr","year":"2016","unstructured":"Sakr RA, Schizas M, Carniello JV, Ng CK, Piscuoglio S, Giri D, Andrade VP, De Brot M, Lim RS, Towers R, Weigelt B, Reis-Filho JS, King TA. Targeted capture massively parallel sequencing analysis of LCIS and invasive lobular cancer: repertoire of somatic genetic alterations and clonal relationships. Mol Oncol. 2016;10:360\u201370.","journal-title":"Mol Oncol"},{"issue":"1","key":"789_CR49","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/gcc.22007","volume":"52","author":"M Christgen","year":"2013","unstructured":"Christgen M, Noskowicz M, Schipper E, Christgen H, Heil C, Krech T, L\u00e4nger F, Kreipe H, Lehmann U. Oncogenic PIK3CA mutations in lobular breast cancer progression. Genes Chromosomes Cancer. 2013;52(1):69\u201380.","journal-title":"Genes Chromosomes Cancer"},{"issue":"1","key":"789_CR50","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.yexmp.2009.09.016","volume":"88","author":"H Li","year":"2009","unstructured":"Li H, Zhu R, Wang L, Zhu T, Li Q, Chen Q, Wang H, Zhu H. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast. Exp Mol Pathol. 2009;88(1):150\u20135.","journal-title":"Exp Mol Pathol"},{"key":"789_CR51","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/modpathol.2013.197","volume":"27","author":"DC Ang","year":"2014","unstructured":"Ang DC, Warrick AL, Shilling A, Beadling C, Corless CL, Troxell ML. Frequent phosphatidylinositol-3-kinase mutations in proliferative breast lesions. Mod Pathol. 2014;27:740\u201350.","journal-title":"Mod Pathol"},{"key":"789_CR52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.molonc.2014.12.005","volume":"9","author":"VP Andrade","year":"2015","unstructured":"Andrade VP, Morrogh M, Qin LX, Olvera N, Giri D, Muhsen S, Sakr RA, Schizas M, Ng CK, Arroyo CD, Brogi E, Viale A, Morrow M, Reis-Filho JS, King TA. Gene expression profiling of lobular carcinoma in situ reveals candidate precursor genes for invasion. Mol Oncol. 2015;9:772\u201382.","journal-title":"Mol Oncol"},{"issue":"11","key":"789_CR53","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/1940-6207.CAPR-10-0108","volume":"3","author":"LM Merlo","year":"2010","unstructured":"Merlo LM, Shah NA, Li X, Blount PL, Vaughan TL, Reid BJ, Maley CC. A comprehensive survey of clonal diversity measures in Barrett\u2019s esophagus as biomarkers of progression to esophageal adenocarcinoma. Cancer Prev Res. 2010;3(11):1388\u201397.","journal-title":"Cancer Prev Res"},{"issue":"4","key":"789_CR54","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/ng1768","volume":"38","author":"CC Maley","year":"2006","unstructured":"Maley CC, Galipeau PC, Finley JC, Wongsurawat VJ, Li X, Sanchez CA, Paulson TG, Blount PL, Risques RA, Rabinovitch PS, Reid BJ. Genetic clonal diversity predicts progression to esophageal adenocarcinoma. Nat Genet. 2006;38(4):468\u201373.","journal-title":"Nat Genet"},{"issue":"4","key":"789_CR55","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.trecan.2015.10.005","volume":"1","author":"M Zhang","year":"2015","unstructured":"Zhang M, Rosen JM. Developmental insights into breast cancer intratumoral heterogeneity. Trends Cancer. 2015;1(4):242\u201351.","journal-title":"Trends Cancer"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0789-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,5,18]],"date-time":"2018-05-18T11:02:23Z","timestamp":1526641343000},"score":1,"resource":{"primary":{"URL":"http:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-016-0789-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,17]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["789"],"URL":"https:\/\/doi.org\/10.1186\/s13058-016-0789-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,17]]},"article-number":"7"}}